Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 260 participants.
Also called NCT06683040
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 260 participants
- Registry
-
NCT06683040
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06683040. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Drug)
- Oxacom
- Intervention (Drug)
- Placebo
- Lead sponsor
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Record details
- Record id
cardio:ct-nct06683040- Content hash
ba974e58204d2a45e7cc80662724c17693fbc158fb16224f987883274e26ae60